Registry for monitoring CytoSorb device use in critically ill patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to collect and analyze data on the use of the CytoSorb device in real-world critical care settings. It will provide a comprehensive and scientifically-based resource to measure and improve the quality of patient care for conditions such as septic shock and acute respiratory distress syndrome. The registry will include patients who have given informed consent and are planned to receive the CytoSorb treatment. By documenting outcomes and experiences, the registry seeks to enhance understanding and application of this therapy in critical situations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Planned OR actual CytoSorb® 300 mL device utilization
2. Informed consent for prospective registry participation

Exclusion Criteria:

1. Use of the CytoSorb® 300 mL device for antithrombotic removal only
2. Intraoperative use of CytoSorb® 300 mL device during cardiac surgery only
3. The occurrence of a complication or other medically justified circumstance that arises after written informed consent has been obtained from the patient and before or during the planned therapy and as a result of which the use of CytoSorb® 300 mL Adsorber is contraindicated or no longer appropriate.

Where it's running

• Klinikum Klagenfurt am Wörthersee
  Klagenfurt, Austria Recruiting
• Medizinische Universität Wien
  Vienna, Austria Recruiting
• Universitätsklinikum Aachen
  Aachen, Germany Recruiting
• Herz- und Diabeteszentrum Nordrhein-Westfalen
  Bad Oeynhausen, Germany Recruiting
• Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum
  Bochum, Germany Recruiting
• Katholisches Klinikum Bochum, St. Josef-Hospital
  Bochum, Germany Recruiting

Study contacts

• Principal investigator: Ricard Ferrer Roca, MD — Hospital Vall d'Hebron
• Study coordinator: Robert Wilke
• Email: cosmos@cytosorbents.com
• Phone: +49 30 654 99 145

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing Interleukin 6 and Procalcitonin for Sepsis Detection in Burn Patients

  This study is testing whether measuring Interleukin-6 can help doctors find sepsis in burn patients better than the usual test with procalcitonin.

  Recruiting Ain Shams University · Cairo · NCT06915974

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• Non-invasive hemodynamic guidance for sepsis care on medical wards

  This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.

  Recruiting at 2 sites Regione del Veneto - AULSS n. 7 Pedemontana · Pisa, Pisa and 1 other locations · NCT07863323

• Personalized Fluid Resuscitation in the Emergency Department

  This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.

  Recruiting Intermountain Health Care, Inc. · Murray, Utah · NCT07779720

• Discordance between capillary refill time and oxygen use in septic shock

  This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.

  Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT07774962

• Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock

  This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.

  Recruiting Alexandria University · Alexandria, Alexandria Governorate · NCT07716956

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.